— Know what they know.
Not Investment Advice
Also trades as: GTII.CN (CNQ) · $vol 1M

GTBIF OTC

Green Thumb Industries Inc.
1W: -8.4% 1M: -1.8% 3M: +8.5% YTD: -13.1% 1Y: +26.2% 3Y: -2.2% 5Y: -76.1%
$7.21
+0.18 (+2.56%)
 
Weekly Expected Move ±15.1%
$5 $6 $7 $8 $9
OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Alpha Radar Sell · Power 42 · $1.6B mcap · 190M float · 0.352% daily turnover · Short 51% of daily vol
Smart Money Score
Watch 25
Insider
Congress
ETF Holdings
Key Statistics
Market Cap$1.6B
52W Range4.8-10.43
Volume114,749
Avg Volume668,743
Beta0.93
Dividend
Analyst Ratings
5 Buy 0 Hold 0 Sell
Consensus Buy
Company Info
CEOBenjamin Kovler
Employees4,900
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
IPO Date2018-06-14
325 West Huron Street
Chicago, IL 60654
US
312 471 6720
About Green Thumb Industries Inc.

Green Thumb Industries Inc. engages in manufacture, distribution, and sale of various cannabis products for medical and adult-use in the United States. It offers cannabis flower; and processed and packaged products, including pre-rolls, concentrates, vapes, tinctures, edibles, topicals, and other cannabis-related products under the Beboe, Dogwalkers, Doctor Solomon's, Good Green, incredibles, and RHYTHM brands. The company distributes its products primarily to third-party retail stores, as well as sells finished products directly to consumers in its own retail stores. As of April 11, 2022, it owned and operated 77 retail stores in the United States. The company was founded in 2014 and is headquartered in Chicago, Illinois.

Recent Insider Trades

NameTypeSharesPriceDate
FAULKNER Mathew F-InKind 3,423 $10.90 2024-01-02
Kravitz Bret F-InKind 3,080 $10.90 2024-01-02
Buchan Hannah Scofie A-Award 4,170 2023-12-01
Reisin Richard A-Award 4,170 2023-12-01
Nadelmann Ethan A-Award 4,170 2023-12-01

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms